Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RUPP Anxiety Study
NCT00000389Phase 3Completed
- Sponsor
- National Institute of Mental Health
- Start
- Oct 1996
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of fluvoxamine in generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD), separation anxiety disorder (SAD), sponsored by National Institute of Mental Health. Started Oct 1996; status: completed.
02
Drugs
fluvoxamine
03
Conditions
generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)separation anxiety disorder (SAD)
Beyond the preview
Go deeper on NCT00000389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000389.